Estimation of Socioeconomic Burden of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) in Japa
Not Applicable
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Registration Number
- JPRN-UMIN000051654
- Lead Sponsor
- Takeda Pharmaceutical Company Limited.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 1800
Inclusion Criteria
Not provided
Exclusion Criteria
A web-based questionnaire Survey -Not applicable Database analysis -Not applicable
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Socioeconomic Burden of Adult ADHD The costs of medical care, social security services, and productivity loss (the cost of lost employment, reduced salary and reduced work productivity defined by absenteeism and presenteeism) in adult ADHD patients and productivity loss in adult families of adult ADHD patients and their aggregate values are estimated.
- Secondary Outcome Measures
Name Time Method